O

Ocular Therapeutix
D

OCUL

8.73000
USD
0.00
(0.00%)
مفتوح الان
حجم التداول
19,198
الربح لكل سهم
-1
العائد الربحي
-
P/E
-8
حجم السوق
1,392,279,693
أصول ذات صلة
ABBV
ABBV
-0.660
(-0.35%)
190.370 USD
A
ACAD
0.300
(1.38%)
22.010 USD
A
AVDL
-0.14000
(-1.46%)
9.44000 USD
BMY
BMY
-1.180
(-2.37%)
48.580 USD
JNJ
JNJ
-2.120
(-1.35%)
154.900 USD
REGN
REGN
1.66
(0.31%)
531.05 USD
المزيد
الأخبار المقالات

العنوان: Ocular Therapeutix

القطاع: Healthcare
الصناعة: Biotechnology
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.